Pacira Pharmaceuticals (PCRX)

Add to Watchlists
Create an Alert
77.62 +0.04  +0.05% NASDAQ May 22, 8:00PM Delayed 2m USD

Pacira Pharmaceuticals Enterprise Value:

2.778B for May 22, 2015

View 4,000+ financial data types

View Full Chart

Pacira Pharmaceuticals Enterprise Value Chart

Export Data
Save Image

Pacira Pharmaceuticals Historical Enterprise Value Data

View and export this data going back to 2011. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
May 22, 2015 2.778B
May 21, 2015 2.777B
May 20, 2015 2.793B
May 19, 2015 2.820B
May 18, 2015 2.818B
May 15, 2015 2.786B
May 14, 2015 2.751B
May 13, 2015 2.660B
May 12, 2015 2.701B
May 11, 2015 2.686B
May 8, 2015 2.654B
May 7, 2015 2.556B
May 6, 2015 2.447B
May 5, 2015 2.346B
May 4, 2015 2.386B
May 1, 2015 2.457B
April 30, 2015 2.445B
April 29, 2015 2.942B
April 28, 2015 2.942B
April 27, 2015 2.976B
April 24, 2015 3.049B
April 23, 2015 3.020B
April 22, 2015 2.988B
April 21, 2015 3.003B
April 20, 2015 3.009B
   
April 17, 2015 3.026B
April 16, 2015 2.983B
April 15, 2015 3.307B
April 14, 2015 3.201B
April 13, 2015 3.196B
April 10, 2015 3.136B
April 9, 2015 3.131B
April 8, 2015 3.210B
April 7, 2015 3.105B
April 6, 2015 3.074B
April 2, 2015 3.104B
April 1, 2015 3.066B
March 31, 2015 3.178B
March 30, 2015 3.234B
March 27, 2015 3.302B
March 26, 2015 3.248B
March 25, 2015 3.205B
March 24, 2015 3.338B
March 23, 2015 3.389B
March 20, 2015 3.485B
March 19, 2015 3.488B
March 18, 2015 3.503B
March 17, 2015 3.432B
March 16, 2015 3.464B
March 13, 2015 3.313B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

PCRX Enterprise Value Benchmarks

Companies
Impax Laboratories 3.568B
Sucampo Pharmaceuticals 648.67M
Evoke Pharma 22.16M

PCRX Enterprise Value Range, Past 5 Years

Minimum 85.58M Apr 14 2011
Maximum 4.269B Feb 25 2015
Average 1.382B

PCRX Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("PCRX", "enterprise_value")
  • Last 5 data points: =YCS("PCRX", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.